Literature DB >> 14007730

The reserpine-treated cat.

P WITHRINGTON, E ZAIMIS.   

Abstract

In cats, 24 hr after the administration of 1 mg/kg of reserpine, it was found that (a) the heart is in failure; (b) the sensitivity of the peripheral vessels to adrenaline, noradrenaline and isoprenaline, administered intravenously or close-arterially, is decreased; (c) any blood pressure changes are, as a rule, secondary to changes in heart contraction; and (d) the peripheral blood flow passively follows the blood pressure changes. Furthermore, any improvement of the circulation at this stage was found to be almost exclusively the result of an amelioration in the force of cardiac contraction.

Entities:  

Keywords:  HEART/pharmacology; RESERPINE/pharmacology

Mesh:

Substances:

Year:  1961        PMID: 14007730      PMCID: PMC1482089          DOI: 10.1111/j.1476-5381.1961.tb01124.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  7 in total

1.  Increased rate of metabolism of epinephrine and norepinephrine by sympathomimetic amines.

Authors:  J AXELROD; R TOMCHICK
Journal:  J Pharmacol Exp Ther       Date:  1960-12       Impact factor: 4.030

2.  Reserpine-induced circulatory failure.

Authors:  E ZAIMIS
Journal:  Nature       Date:  1961-11-11       Impact factor: 49.962

3.  The action of sympathomimetic amines in animals treated with reserpine.

Authors:  J H BURN; M J RAND
Journal:  J Physiol       Date:  1958-12-04       Impact factor: 5.182

4.  Cardiac failure with reserpine.

Authors:  E MARLEY; C M PARE
Journal:  Br Med J       Date:  1956-02-04

5.  Direct measurement of changes in cardiac contractile force; relationship of such measurements to stroke work, isometric pressure gradient and other parameters of cardiac function.

Authors:  E BAY; M D COTTEN
Journal:  Am J Physiol       Date:  1956-09

6.  Edema and congestive failure related to administration of Rauwolfia serpentina.

Authors:  G A PERERA
Journal:  J Am Med Assoc       Date:  1955-10-01

7.  Experiments on the post contraction hyperaemia of skeletal muscle.

Authors:  S M HILTON
Journal:  J Physiol       Date:  1953-04-28       Impact factor: 5.182

  7 in total
  14 in total

1.  THE EFFECT OF RESERPINE PRETREATMENT ON THE HYPOTENSIVE ACTION OF THIOPENTAL.

Authors:  J M STUMP; W W FLEMING
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-05-11

2.  SOME FACTORS INFLUENCING THE RECOVERY OF ISOLATED MYOCARDIUM FROM ACUTE ANOXIA.

Authors:  R G PENN
Journal:  Br J Pharmacol Chemother       Date:  1965-02

3.  Some factors affecting ouabain-induced ventricular arrhythmia in the reserpine-treated cat.

Authors:  F Ciofalo; B Levitt; J Roberts
Journal:  Br J Pharmacol Chemother       Date:  1967-05

4.  Is pressure work of the isolated canine heart dependent on release of catecholamines?

Authors:  G Fawaz; J Simaan
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

5.  The mechanism of the pressor action of noradrenaline in pithed cats.

Authors:  S M Karim
Journal:  Br J Pharmacol Chemother       Date:  1966-05

6.  The effect of endogenous catecholamines and norepinephrine administration on the performance of the isolated canine heart.

Authors:  J Simaan; G Fawaz
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

7.  The influence of hypothalamically administered reserpine on the sexual behavior of the female cat.

Authors:  V A Cerny
Journal:  Psychopharmacology (Berl)       Date:  1976-11-24       Impact factor: 4.530

8.  Restoration of tyramine responses by bretylium, BW392C60, bethanidine and monoamine oxidase inhibitors in reserpine-treated rats.

Authors:  D E Clarke
Journal:  Br J Pharmacol       Date:  1970-01       Impact factor: 8.739

9.  The effect of reserpine on the pressor responses to angiotensin in the conscious cat.

Authors:  M D Day; D A Owen
Journal:  Br J Pharmacol       Date:  1970-06       Impact factor: 8.739

10.  SOME OBSERVATIONS ON THE PHARMACOLOGY OF ALPHA-METHYLDOPA.

Authors:  M D DAY; M J RAND
Journal:  Br J Pharmacol Chemother       Date:  1964-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.